Vitiligo associated with bcg-methanoi extraction residue in malignant melanoma: Report of a case

Y. Cohen; S. Haim; A. Bartal; E. Robinson

doi:10.1159/000250737

Vitiligo associated with bcg-methanoi extraction residue in malignant melanoma: Report of a case

Y. Cohen, S. Haim, A. Bartal, E. Robinson

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

A pronounced vitiliginous reaction developed at the sites of MER/BCG injections given as an adjuvant immunotherapy to a patient with malignant melanoma. To our knowledge, this is the third report on patients exhibiting vitiligo apparently induced by immunotherapy and the first in association with MER. This association may be a sign for an antimelanocytic effect and may offer a further confirmation for the autoimmune nature of vitiligo.

Original language	English
Pages (from-to)	8-12
Number of pages	5
Journal	Dermatology
Volume	158
Issue number	1
DOIs	https://doi.org/10.1159/000250737
State	Published - 1 Jan 1979
Externally published	Yes

Keywords

Adjuvant immunotherapy
Malignant melanoma
Treatment with MER/ BCG
Vitiliginous reaction

ASJC Scopus subject areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1159/000250737

Cite this

@article{a879ab90f08c4c8bb688002f25f5be1e,

title = "Vitiligo associated with bcg-methanoi extraction residue in malignant melanoma: Report of a case",

abstract = "A pronounced vitiliginous reaction developed at the sites of MER/BCG injections given as an adjuvant immunotherapy to a patient with malignant melanoma. To our knowledge, this is the third report on patients exhibiting vitiligo apparently induced by immunotherapy and the first in association with MER. This association may be a sign for an antimelanocytic effect and may offer a further confirmation for the autoimmune nature of vitiligo.",

keywords = "Adjuvant immunotherapy, Malignant melanoma, Treatment with MER/ BCG, Vitiliginous reaction",

author = "Y. Cohen and S. Haim and A. Bartal and E. Robinson",

year = "1979",

month = jan,

day = "1",

doi = "10.1159/000250737",

language = "English",

volume = "158",

pages = "8--12",

journal = "Dermatology",

issn = "1018-8665",

publisher = "S. Karger AG",

number = "1",

}

TY - JOUR

T1 - Vitiligo associated with bcg-methanoi extraction residue in malignant melanoma

T2 - Report of a case

AU - Cohen, Y.

AU - Haim, S.

AU - Bartal, A.

AU - Robinson, E.

PY - 1979/1/1

Y1 - 1979/1/1

N2 - A pronounced vitiliginous reaction developed at the sites of MER/BCG injections given as an adjuvant immunotherapy to a patient with malignant melanoma. To our knowledge, this is the third report on patients exhibiting vitiligo apparently induced by immunotherapy and the first in association with MER. This association may be a sign for an antimelanocytic effect and may offer a further confirmation for the autoimmune nature of vitiligo.

AB - A pronounced vitiliginous reaction developed at the sites of MER/BCG injections given as an adjuvant immunotherapy to a patient with malignant melanoma. To our knowledge, this is the third report on patients exhibiting vitiligo apparently induced by immunotherapy and the first in association with MER. This association may be a sign for an antimelanocytic effect and may offer a further confirmation for the autoimmune nature of vitiligo.

KW - Adjuvant immunotherapy

KW - Malignant melanoma

KW - Treatment with MER/ BCG

KW - Vitiliginous reaction

UR - http://www.scopus.com/inward/record.url?scp=0018383297&partnerID=8YFLogxK

U2 - 10.1159/000250737

DO - 10.1159/000250737

M3 - Article

AN - SCOPUS:0018383297

SN - 1018-8665

VL - 158

SP - 8

EP - 12

JO - Dermatology

JF - Dermatology

IS - 1

ER -

Vitiligo associated with bcg-methanoi extraction residue in malignant melanoma: Report of a case

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this